1. Home
  2. CNXC vs AGIO Comparison

CNXC vs AGIO Comparison

Compare CNXC & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNXC
  • AGIO
  • Stock Information
  • Founded
  • CNXC 1991
  • AGIO 2007
  • Country
  • CNXC United States
  • AGIO United States
  • Employees
  • CNXC N/A
  • AGIO N/A
  • Industry
  • CNXC Computer Software: Prepackaged Software
  • AGIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • CNXC Technology
  • AGIO Health Care
  • Exchange
  • CNXC Nasdaq
  • AGIO Nasdaq
  • Market Cap
  • CNXC 3.0B
  • AGIO 2.4B
  • IPO Year
  • CNXC N/A
  • AGIO 2013
  • Fundamental
  • Price
  • CNXC $40.48
  • AGIO $35.42
  • Analyst Decision
  • CNXC Buy
  • AGIO Buy
  • Analyst Count
  • CNXC 5
  • AGIO 7
  • Target Price
  • CNXC $79.00
  • AGIO $56.33
  • AVG Volume (30 Days)
  • CNXC 775.2K
  • AGIO 1.1M
  • Earning Date
  • CNXC 01-22-2025
  • AGIO 02-13-2025
  • Dividend Yield
  • CNXC 3.29%
  • AGIO N/A
  • EPS Growth
  • CNXC N/A
  • AGIO N/A
  • EPS
  • CNXC 3.08
  • AGIO 11.80
  • Revenue
  • CNXC $9,401,638,000.00
  • AGIO $32,871,000.00
  • Revenue This Year
  • CNXC $37.84
  • AGIO $33.38
  • Revenue Next Year
  • CNXC $1.69
  • AGIO $163.06
  • P/E Ratio
  • CNXC $13.15
  • AGIO $3.00
  • Revenue Growth
  • CNXC 44.09
  • AGIO 36.79
  • 52 Week Low
  • CNXC $36.28
  • AGIO $20.96
  • 52 Week High
  • CNXC $106.10
  • AGIO $62.58
  • Technical
  • Relative Strength Index (RSI)
  • CNXC 39.27
  • AGIO 28.75
  • Support Level
  • CNXC $41.65
  • AGIO $37.20
  • Resistance Level
  • CNXC $43.84
  • AGIO $44.46
  • Average True Range (ATR)
  • CNXC 2.12
  • AGIO 4.27
  • MACD
  • CNXC -0.38
  • AGIO -2.06
  • Stochastic Oscillator
  • CNXC 11.50
  • AGIO 1.06

About CNXC Concentrix Corporation

Concentrix Corp is a technology-enabled company specialized in customer engagement and customer management. The company provides end-to-end capabilities, including CX process optimization, technology innovation and design engineering, front- and back-office automation, analytics and business transformation services to clients in five primary industry verticals. The Company's verticals are technology and consumer electronics, retail, travel and e-commerce, communications and media, banking, financial services and insurance, and healthcare. Geographically, the company operates in Philippines, Unites States, India, Canada, Germany, Great Britain and others.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.

Share on Social Networks: